Cargando…
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L
The linear ubiquitin chain assembly complex (LUBAC), composed of HOIP, HOIL-1 and SHARPIN, is required for optimal TNF-mediated gene activation and to prevent cell death induced by TNF. Here, we demonstrate that keratinocyte-specific deletion of HOIP or HOIL-1 (E-KO) results in severe dermatitis cau...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156229/ https://www.ncbi.nlm.nih.gov/pubmed/30254289 http://dx.doi.org/10.1038/s41467-018-06155-8 |
_version_ | 1783358060148817920 |
---|---|
author | Taraborrelli, Lucia Peltzer, Nieves Montinaro, Antonella Kupka, Sebastian Rieser, Eva Hartwig, Torsten Sarr, Aida Darding, Maurice Draber, Peter Haas, Tobias L. Akarca, Ayse Marafioti, Teresa Pasparakis, Manolis Bertin, John Gough, Peter J. Bouillet, Philippe Strasser, Andreas Leverkus, Martin Silke, John Walczak, Henning |
author_facet | Taraborrelli, Lucia Peltzer, Nieves Montinaro, Antonella Kupka, Sebastian Rieser, Eva Hartwig, Torsten Sarr, Aida Darding, Maurice Draber, Peter Haas, Tobias L. Akarca, Ayse Marafioti, Teresa Pasparakis, Manolis Bertin, John Gough, Peter J. Bouillet, Philippe Strasser, Andreas Leverkus, Martin Silke, John Walczak, Henning |
author_sort | Taraborrelli, Lucia |
collection | PubMed |
description | The linear ubiquitin chain assembly complex (LUBAC), composed of HOIP, HOIL-1 and SHARPIN, is required for optimal TNF-mediated gene activation and to prevent cell death induced by TNF. Here, we demonstrate that keratinocyte-specific deletion of HOIP or HOIL-1 (E-KO) results in severe dermatitis causing postnatal lethality. We provide genetic and pharmacological evidence that the postnatal lethal dermatitis in Hoip(E-KO) and Hoil-1(E-KO) mice is caused by TNFR1-induced, caspase-8-mediated apoptosis that occurs independently of the kinase activity of RIPK1. In the absence of TNFR1, however, dermatitis develops in adulthood, triggered by RIPK1-kinase-activity-dependent apoptosis and necroptosis. Strikingly, TRAIL or CD95L can redundantly induce this disease-causing cell death, as combined loss of their respective receptors is required to prevent TNFR1-independent dermatitis. These findings may have implications for the treatment of patients with mutations that perturb linear ubiquitination and potentially also for patients with inflammation-associated disorders that are refractory to inhibition of TNF alone. |
format | Online Article Text |
id | pubmed-6156229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61562292018-09-27 LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L Taraborrelli, Lucia Peltzer, Nieves Montinaro, Antonella Kupka, Sebastian Rieser, Eva Hartwig, Torsten Sarr, Aida Darding, Maurice Draber, Peter Haas, Tobias L. Akarca, Ayse Marafioti, Teresa Pasparakis, Manolis Bertin, John Gough, Peter J. Bouillet, Philippe Strasser, Andreas Leverkus, Martin Silke, John Walczak, Henning Nat Commun Article The linear ubiquitin chain assembly complex (LUBAC), composed of HOIP, HOIL-1 and SHARPIN, is required for optimal TNF-mediated gene activation and to prevent cell death induced by TNF. Here, we demonstrate that keratinocyte-specific deletion of HOIP or HOIL-1 (E-KO) results in severe dermatitis causing postnatal lethality. We provide genetic and pharmacological evidence that the postnatal lethal dermatitis in Hoip(E-KO) and Hoil-1(E-KO) mice is caused by TNFR1-induced, caspase-8-mediated apoptosis that occurs independently of the kinase activity of RIPK1. In the absence of TNFR1, however, dermatitis develops in adulthood, triggered by RIPK1-kinase-activity-dependent apoptosis and necroptosis. Strikingly, TRAIL or CD95L can redundantly induce this disease-causing cell death, as combined loss of their respective receptors is required to prevent TNFR1-independent dermatitis. These findings may have implications for the treatment of patients with mutations that perturb linear ubiquitination and potentially also for patients with inflammation-associated disorders that are refractory to inhibition of TNF alone. Nature Publishing Group UK 2018-09-25 /pmc/articles/PMC6156229/ /pubmed/30254289 http://dx.doi.org/10.1038/s41467-018-06155-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Taraborrelli, Lucia Peltzer, Nieves Montinaro, Antonella Kupka, Sebastian Rieser, Eva Hartwig, Torsten Sarr, Aida Darding, Maurice Draber, Peter Haas, Tobias L. Akarca, Ayse Marafioti, Teresa Pasparakis, Manolis Bertin, John Gough, Peter J. Bouillet, Philippe Strasser, Andreas Leverkus, Martin Silke, John Walczak, Henning LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L |
title | LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L |
title_full | LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L |
title_fullStr | LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L |
title_full_unstemmed | LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L |
title_short | LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L |
title_sort | lubac prevents lethal dermatitis by inhibiting cell death induced by tnf, trail and cd95l |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156229/ https://www.ncbi.nlm.nih.gov/pubmed/30254289 http://dx.doi.org/10.1038/s41467-018-06155-8 |
work_keys_str_mv | AT taraborrellilucia lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT peltzernieves lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT montinaroantonella lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT kupkasebastian lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT riesereva lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT hartwigtorsten lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT sarraida lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT dardingmaurice lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT draberpeter lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT haastobiasl lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT akarcaayse lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT marafiotiteresa lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT pasparakismanolis lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT bertinjohn lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT goughpeterj lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT bouilletphilippe lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT strasserandreas lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT leverkusmartin lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT silkejohn lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l AT walczakhenning lubacpreventslethaldermatitisbyinhibitingcelldeathinducedbytnftrailandcd95l |